Scientists supercharge Patients' own immune cells to fight advanced cancer
NCT ID NCT05902520
Summary
This is a first-in-human study testing a new personalized cell therapy for people with advanced solid tumors that have not responded to standard treatments. Doctors take a patient's own tumor-fighting immune cells from a tumor sample, grow large numbers of the most potent ones in a lab, and then infuse them back into the patient. The study aims to see if this approach is safe and if adding a genetic tweak to these cells makes them even more effective at fighting cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
Conditions
Explore the condition pages connected to this study.